Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.

  • Patrick Fitzgerald (Speaker)
  • D. M. Harris (Speaker)
  • Suzanne Crotty (Speaker)
  • A. J. Harkin (Speaker)
  • Arkady Mandel (Speaker)
  • Anthony E. Bolton (Speaker)
  • Sullivan, A. (Speaker)
  • Nolan, Y. (Speaker)

Activity: Talk or presentation › Invited talk

Description

[Invited Lectures (Conference)], Society for Neuroscience meeting, Washington, USA, Washington DC, USA , 11-DEC-05 - 16-NOV-05.
Period12 Nov 2005 → 16 Nov 2005
Event titleSociety for Neuroscience meeting
Event typeConference
LocationWashington, United StatesShow on map